These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 11729404

  • 1. Roundtable. Blueprint for conversion of patients on metformin and sulfonylurea to Glucovance.
    Roselli A, Hayes JD, Seidner R, Marchione V, Snyder CM, Mayes K, Stiernberg CM, Milgram L.
    Manag Care; 2001 Feb; 10(2 Suppl):17-21. PubMed ID: 11729404
    [No Abstract] [Full Text] [Related]

  • 2. Glyburide/metformin (Glucovance) for type 2 diabetes.
    Med Lett Drugs Ther; 2000 Nov 13; 42(1092):105-6. PubMed ID: 11077467
    [No Abstract] [Full Text] [Related]

  • 3. [Metformin--its regimen and effects].
    Shiba T.
    Nihon Rinsho; 2002 Sep 13; 60 Suppl 9():382-8. PubMed ID: 12387022
    [No Abstract] [Full Text] [Related]

  • 4. [Sulfonylurea compounds or biguanides in the treatment of type 2 diabetes?].
    Mehnert H.
    Dtsch Med Wochenschr; 1989 Jul 07; 114(27):1086-8. PubMed ID: 2500320
    [No Abstract] [Full Text] [Related]

  • 5. [Efficacy and safety of glimepiride plus metformin in a single presentation, as combined therapy, in patients with type 2 diabetes mellitus and secondary failure to glibenclamide, as monotherapy].
    González-Ortiz M, Martínez-Abundis E, Grupo para el Tratamiento de la Diabetes Mellitus con Combinaciones.
    Rev Invest Clin; 2004 Jul 07; 56(3):327-33. PubMed ID: 15612515
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Therapy with oral antidiabetic agents -- special considerations in the case of coronary heart disease].
    Nauck MA, Matthaei S.
    Dtsch Med Wochenschr; 2005 Apr 29; 130(17):1091-6. PubMed ID: 15841424
    [No Abstract] [Full Text] [Related]

  • 8. [Medication of the month. Glucovance in type 2 diabetes, a fixed combination of metformin-glibenclamide for the treatment of a bipolar metabolic disease].
    Scheen AJ.
    Rev Med Liege; 2003 Jun 29; 58(6):448-52. PubMed ID: 12945247
    [Abstract] [Full Text] [Related]

  • 9. Combination agents for diabetes.
    Samuel J, Rochester CD.
    Adv Nurse Pract; 2003 Jun 29; 11(6):22-4. PubMed ID: 12807051
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Sitagliptin + metformin: new combination. Do not use this combination. Sitagliptin provides a slight increase of glucose-lowering effects, but there is a disturbing potential for long-term adverse effects: infections, depression, and cancer.
    Prescrire Int; 2009 Jun 29; 18(101):115. PubMed ID: 19637427
    [No Abstract] [Full Text] [Related]

  • 12. Practical considerations and guidelines for dosing sulfonylureas as monotherapy or combination therapy.
    Bell DS.
    Clin Ther; 2004 Nov 29; 26(11):1714-27. PubMed ID: 15639686
    [Abstract] [Full Text] [Related]

  • 13. Sulphonylurea-metformin combination therapy, cardiovascular disease and all-cause mortality: the Fremantle Diabetes Study.
    Sillars B, Davis WA, Hirsch IB, Davis TM.
    Diabetes Obes Metab; 2010 Sep 29; 12(9):757-65. PubMed ID: 20649627
    [Abstract] [Full Text] [Related]

  • 14. Impact of oral antihyperglycemic therapy on all-cause mortality among patients with diabetes in the Veterans Health Administration.
    Kahler KH, Rajan M, Rhoads GG, Safford MM, Demissie K, Lu SE, Pogach LM.
    Diabetes Care; 2007 Jul 29; 30(7):1689-93. PubMed ID: 17440170
    [Abstract] [Full Text] [Related]

  • 15. The UK Prospective Diabetes Study.
    Bailey CJ, Grant PJ.
    Lancet; 1998 Dec 12; 352(9144):1932; author reply 1934. PubMed ID: 9863806
    [No Abstract] [Full Text] [Related]

  • 16. The UK Prospective Diabetes Study.
    Evans M.
    Lancet; 1998 Dec 12; 352(9144):1932-3; author reply 1934. PubMed ID: 9863807
    [No Abstract] [Full Text] [Related]

  • 17. [Formulation by design of experiments of immediate release tablets with metformin hydrochloride and glibenclamide].
    Potur RG, Gafiţanu E.
    Rev Med Chir Soc Med Nat Iasi; 2010 Dec 12; 114(4):1219-26. PubMed ID: 21500483
    [Abstract] [Full Text] [Related]

  • 18. Race, ethnicity, and use of thiazolidinediones among US adults with diabetes.
    Aquilante CL, Zhang W, McCollum M.
    Curr Med Res Opin; 2007 Mar 12; 23(3):489-94. PubMed ID: 17355730
    [Abstract] [Full Text] [Related]

  • 19. [Triple oral therapy in type 2 diabetes].
    Scheen AJ.
    Rev Med Suisse; 2005 Aug 24; 1(30):1942, 1944-6, 1948. PubMed ID: 16200937
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.